Smead Value Fund
SMVLX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 2777 East Camelback Road, Suite 375 Phoenix AZ United States of America 85016
- IPO Date
- Jan 2, 2008
- CIK
- 0001614370
- Website
- smeadcap.com
- Similar Companies
- Business
- Smead Value Fund (SMVLX) is an open-end mutual fund that employs a low-turnover, differentiated value investment discipline, primarily investing in common stocks of 25-30 large-cap U.S. companies with market capitalizations exceeding $5 billion, selected based on eight proprietary criteria including economic need, strong competitive advantages, profitability, free cash flow generation, and attractive pricing relative to intrinsic value. The fund offers multiple share classes including Investor Class (SMVLX), A Class (SVFAX), C Class (SVFCX), I1 Class (SVFFX), R1 Class (SVFDX), R2 Class (SVFKX), and Y Class (SVFYX), with varying expense ratios from 0.80% for Y shares to 1.80% for C shares; it maintains sector allocations such as consumer discretionary (24.52%), energy (23.92%), financials (19.33%), real estate (12.31%), and healthcare (11.91%) as of September 30, 2025, with top holdings including Simon Property Group Inc., D.R. Horton Inc., American Express Co., Macerich Co., and Cenovus Energy Inc. Launched on January 2, 2008, and advised by Smead Capital Management, Inc., a Phoenix, Arizona-based registered investment adviser founded in 2007 with additional offices in Jersey City, New Jersey, and London, United Kingdom, the fund targets long-term investors including individuals, advisors, family offices, and institutions seeking wealth building through undervalued, high-quality companies. In recent portfolio adjustments during 2025, the fund initiated new positions in UnitedHealth Group Inc. (286,744 shares, 1.99% of portfolio) and Crocs Inc. (552,392 shares, 1.08%), significantly increased stakes in Diamondback Energy Inc. (21.26% share increase) and Target Corp. (23.39% share increase), while fully exiting three unnamed holdings in the third quarter; earlier in the year, it added Millrose Properties Inc. (1,081,478 shares, 0.46%) and boosted its Merck & Co Inc. position by 4.81%. The strategy remains non-diversified, with approximately 90% in U.S. stocks, 5% cash, and 4-5% non-U.S. stocks, distributed by Smead Funds Distributors, LLC, and available primarily to U.S. residents with a minimum initial investment of $3,000 for Investor Class shares.